Members: 0 member(s)

Shares ?

0

Clicks ?

0

Viral Lift ?

0%

Entrepreneurship 47 views Aug 08, 2018
Xarelto Lawsuit Is Crucial To Your Business. Learn Why!
xarelto rivaroxaban 20 mgOur attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical businesses, such as the makers of Xarelto, possess a duty to ensure that their drugs are reasonably secure for use - and failure to perform so might be grounds for compensation. Our lawyers are operating challenging to have these hurt by the drug the compensation they're entitled to.

Whilst bleeding is actually a typical complication linked with anticoagulants, it has been alleged that Xarelto is much more hazardous than conventional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This indicates that, in the event of an emergency, sufferers might be at danger for irreversible bleeding issues, like life-threatening internal and gastrointestinal hemorrhaging.

If you or perhaps a loved 1 http://xareltoattorneys.bitbucket.org suffered a serious bleeding event soon after taking Xarelto, you may have legal recourse. For much more data, contact us today to have your case reviewed, free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, pain and suffering and, in cases of death, funeral costs. Additionally, they're seeking punitive damages, that are usually awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Getting Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs inside the lawsuits allege significant and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.

Visit this page for much more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

how to stop bleeding when on blood thinnersThe attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.